MedImmuneThis role supports MedImmune’s goals for a new generation of peptide leads for a sustainable pipeline of biologic drugs. You will work closely with multiple therapeutic areas to identify new peptide-based therapeutics and you will act as co-leader on peptide drug projects. You will direct experimental strategy and perform practical synthetic chemistry for the development of novel peptide therapeutics.
There will be both hands on laboratory and desk based aspects to the role involving performance of experimental work directly and through supervision as well as accountability for the technical and synthesis strategy and execution on peptide projects. You would report to the head of the group and would be expected to gradually take over key responsibilities for team performance and strategy.
Responsibilities include:
You are likely to hold a relevant PhD and postdoctoral experience (or equivalent) in peptide, organic or medicinal chemistry. Experience with synthetic peptide chemistry and development of peptide therapeutics for drug discovery is essential. It would be desirable to have project leadership experience.
MedImmune, the global biologics unit of AstraZeneca, is committed to developing better medicines that help people live healthier, longer and more satisfying lives. The company is focused on the areas of infection, respiratory and inflammatory disease, oncology and neuroscience, with two marketed products and a robust pipeline of promising new product candidates. MedImmune’s state-of-the-art Cambridge site (formerly Cambridge Antibody Technology) is home to around 550 employees, and serves the company’s European hub for research and development.
MedImmune is an Equal Opportunities Employer. We seek to empower each individual, and respect the diverse cultures, perspectives, skills and experiences within our work place.